Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel macrocyclic inhibitors of hepatitis C virus replication

A technology of cycloalkylated compounds, applied in the field of novel macrocyclic inhibitors of hepatitis C virus replication, which can address the increased risk of hepatocellular carcinoma, among other issues

Inactive Publication Date: 2011-05-04
INTERMUNE INC
View PDF18 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Specifically, patients with advanced fibrosis or advanced cirrhosis on liver biopsy are at high risk of developing complications of advanced liver disease including ascites, jaundice, variceal hemorrhage, encephalopathy, and progressive liver failure, and hepatocellular Significantly increased risk of cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel macrocyclic inhibitors of hepatitis C virus replication
  • Novel macrocyclic inhibitors of hepatitis C virus replication
  • Novel macrocyclic inhibitors of hepatitis C virus replication

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[1227] Preparation of NS3 inhibitors

[1228] methodology

[1229] The HCV protease inhibitors in each section can be prepared according to the procedures and schemes shown in each section below. Numbering in the following sections (including general methods or general procedure names) for the preparation of NS3 inhibitors refers only to that specific section and should not be interpreted as the same numbering (if any) in other sections or as in other sections. The same number (if any) is confused.

[1230] Preparation of NS3 Inhibitors: Part I

example 1

[1232] General Synthesis A

[1233] Option I

[1234]

[1235] Macrocycles with general structures I-D and I-E can be synthesized as shown in Scheme I. Isoindoline carbamates 1 can be treated under basic conditions to hydrolyze the isoindoline carbamates, thereby yielding alcohols 2. Heteroaryl chlorides such as 2-chlorobenzothiazole, 2-chloro-6-methylbenzothiazole, 2,6-dichlorobenzothiazole, 6-bromo-2-chloro Benzothiazole, 1-chloroisoquinoline, etc., treatment of alcohol 2 affords compounds with general structure I-A. Compounds of general structure I-A can be treated with an acid in methanol to remove the Boc protecting group and form the methyl ester, thereby giving compounds of general structure I-B. Available in Cu 2+ Treatment of compounds of general structure I-B with optionally substituted arylboronic acids under catalytic conditions affords N-aryl compounds of general structure I-C. Compounds of general structure I-C can be treated under basic conditions to...

example 1-1

[1237] General Procedure A

[1238] Compound 1 (10 g, 15.9 mmol) was dissolved in methanol (100 mL), 5M NaOH solution (95 mL) was added, and after the reaction was completed, the resulting mixture was heated to 50° C. and stirred overnight. The mixture was cooled with ice water, 2M HCl was added to acidify the mixture to pH = 3-4, then the mixture was extracted with EtOAc, the organic layers were combined, washed with brine, dried, and the solvent was removed under reduced pressure, the crude compound 2 (7.5 g) was directly used in in the next step.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The embodiments provide compounds of the general Formulae I, II, EI, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods enerally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Description

[0001] Related applications [0002] This application asserts U.S. Provisional Application Nos. 61 / 045,220, filed April 15, 2008; 61 / 105,736, filed October 15, 2008; 61 / 105,751, filed October 15, 2008 ; 61 / 143,728, filed January 9, 2009; and 61 / 150,693, filed February 6, 2009, all of which are hereby incorporated by reference in their entirety. [0003] sequence listing [0004] This application is filed together with a Sequence Listing in electronic format. The sequence listing is provided as a file entitled INTMU-049VPC.TXT created on April 14, 2009, 4 Kb in size. The information in the sequence listing in electronic format is incorporated herein by reference in its entirety. technical field [0005] The invention relates to a compound for treating hepatitis C virus (hepatitis C virus, HCV) infection, a synthesis method thereof, a composition for treating hepatitis C virus infection and a method for treating hepatitis C virus infection. Background technique [0006]...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D471/04C07D487/04A61P1/16A61K38/05A61K38/06C07K5/12A61P31/14
CPCA61K31/407A61K31/4709A61K31/4725A61K31/4738A61K31/517A61K31/7056A61K38/212A61K38/217A61K45/06C07D471/04C07D487/04C07K5/123A61P1/16A61P31/14A61P43/00A61K2300/00
Inventor 斯科特·塞韦特利奥尼德·拜格尔曼布拉德·巴克曼安蒂察·迪米特罗娃·斯托伊切夫瓦斯蒂文·B·波特威廉森·齐格勒·布拉德福德弗拉基米尔·谢列布里亚内
Owner INTERMUNE INC